DCF — USC NORRIS CANCER HOSPITAL
Enterprise Value: $298.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$298.7M
Enterprise Value
$76.0M
PV of Cash Flows
$222.7M
PV of Terminal Value
$358.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $482.7M | $41.0M | 8.0% | $13.4M | $12.1M |
| Year 2 | $497.2M | $47.2M | 9.0% | $17.5M | $14.5M |
| Year 3 | $512.1M | $53.8M | 10.0% | $21.9M | $16.4M |
| Year 4 | $527.5M | $58.0M | 11.0% | $24.5M | $16.7M |
| Year 5 | $543.3M | $61.1M | 11.0% | $26.2M | $16.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $298.7M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$468.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999897585193
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5